Skip to content
10-K

Annual Report

Apotheca Biosciences, Inc.

0001079974-19-000277

← back to feed
Filed
May 16, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · May 15, 2019 118.66M sh
Capex FY 2019 · Jan 31, 2019 $6.62K
Operating Cash Flow FY 2019 · Jan 31, 2019 −$428.24K
Cash And Equivalents FY 2019 · Jan 31, 2019 $2.94K
Cash And Equivalents FY 2019 · Apr 30, 2018 $0
Cash And Equivalents FY 2019 · Feb 25, 2018 $0
Stockholders Equity FY 2019 · Jan 31, 2019 −$816.55K
Stockholders Equity FY 2019 · Apr 30, 2018 −$32.24K
Total Liabilities FY 2019 · Jan 31, 2019 $931.88K
Total Liabilities FY 2019 · Apr 30, 2018 $32.24K
Current Assets FY 2019 · Jan 31, 2019 $108.88K
Current Assets FY 2019 · Apr 30, 2018 $0
Total Assets FY 2019 · Jan 31, 2019 $115.33K
Total Assets FY 2019 · Apr 30, 2018 $0
Sga Expense FY 2019 · Jan 31, 2019 $210.72K
Net Income FY 2019 · Jan 31, 2019 −$2.51M
Operating Income FY 2019 · Jan 31, 2019 −$2.28M
Revenue FY 2019 · Jan 31, 2019 $0
Current Liabilities FY 2019 · Mar 26, 2018 $1.3M